Clinical Trial Update: A Long-Term Extension Study of OnabotulinumtoxinA (BOTOX®) for Urinary Incontinence Due to Neurogenic Detrusor Overactivity [Phase 3]

View source ↗

Summary

A long-term extension study of onabotulinumtoxinA (BOTOX) for urinary incontinence due to neurogenic detrusor overactivity has completed Phase 3 with posted res…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neurogenic Detrusor Overactivity
• Urinary Incontinence

Drugs mentioned

• Botox (OnabotulinumtoxinA)

Snippet

Sponsor: Allergan | Conditions: Urinary Incontinence | Phase 3 | Status: COMPLETED | Results posted: 2020-05-12